- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 235/12 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 235/12
Total number of patents in this class: 191
10-year publication summary
|
14
|
14
|
9
|
9
|
20
|
11
|
11
|
9
|
9
|
5
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ecolab USA Inc. | 5190 |
12 |
| Janssen Pharmaceutica N.V. | 3839 |
8 |
| Epizyme, Inc. | 383 |
7 |
| Astellas Pharma Inc. | 1145 |
6 |
| F. Hoffmann-La Roche AG | 7958 |
5 |
| FUJIFILM Corporation | 27102 |
5 |
| Jiangsu Hengrui Medicine Co., Ltd. | 780 |
5 |
| Boehringer Ingelheim International GmbH | 4629 |
4 |
| Takeda Pharmaceutical Company Limited | 2961 |
4 |
| Nippon Shinyaku Co., Ltd. | 297 |
4 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 588 |
4 |
| UCB Biopharma SPRL | 381 |
4 |
| University of Washington through its Center for Commercialization | 498 |
4 |
| Yale University | 2204 |
4 |
| Allergan, Inc. | 2600 |
3 |
| Glenmark Pharmaceuticals S.A. | 124 |
3 |
| UCB Biopharma SRL | 626 |
3 |
| Tmem16a Limited | 14 |
3 |
| Novartis AG | 11238 |
2 |
| Boehringer Ingelheim Pharma GmbH & Co. Kg | 790 |
2 |
| Other owners | 99 |